Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:7
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 15 条
  • [1] C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer
    Beer, Tomasz M.
    Lalani, Alshad S.
    Lee, Stella
    Mori, Motomi
    Eilers, Kristine M.
    Curd, John G.
    Henner, W. David
    Ryan, Christopher W.
    Venner, Peter
    Ruether, J. Dean
    Chi, Kim N.
    [J]. CANCER, 2008, 112 (11) : 2377 - 2383
  • [2] THE DEVELOPMENT OF HUMAN BENIGN PROSTATIC HYPERPLASIA WITH AGE
    BERRY, SJ
    COFFEY, DS
    WALSH, PC
    EWING, LL
    [J]. JOURNAL OF UROLOGY, 1984, 132 (03) : 474 - 479
  • [3] Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
    Di Silverio, F
    Gentile, V
    De Matteis, A
    Mariotti, G
    Giuseppe, V
    Luigi, PA
    Sciarra, A
    [J]. EUROPEAN UROLOGY, 2003, 43 (02) : 164 - 175
  • [4] Prostate cancer and adiponectin
    Goktas, S
    Yilmaz, MI
    Caglar, K
    Sonmez, A
    Kilic, S
    Bedir, S
    [J]. UROLOGY, 2005, 65 (06) : 1168 - 1172
  • [5] Association between Trace Element and Heavy Metal Levels in Hair and Nail with Prostate Cancer
    Karimi, Golgis
    Shahar, Suzana
    Homayouni, Nasim
    Rajikan, Roslee
    Abu Bakar, Nor Faizah
    Othman, Mohd Sham
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (09) : 4249 - 4253
  • [6] Adiponectin and cancer: a systematic review
    Kelesidis, I
    Kelesidis, T
    Mantzoros, C
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (09) : 1221 - 1225
  • [7] The natural history of benign prostatic hyperplasia: What have we learned in the last decade?
    Kirby, RS
    [J]. UROLOGY, 2000, 56 (5A) : 3 - 6
  • [8] High-Sensitivity C-Reactive Protein and Cancer
    Lee, Seounghee
    Choe, Jae-Won
    Kim, Hong-Kyu
    Sung, Joohon
    [J]. JOURNAL OF EPIDEMIOLOGY, 2011, 21 (03) : 161 - 168
  • [9] Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
    Lu, Jin-Ying
    Huang, Kuo-Chin
    Chang, Lin-Chau
    Huang, Ying-Shing
    Chi, Yu-Chiao
    Su, Ta-Chan
    Chen, Chi-Ling
    Yang, Wei-Shiung
    [J]. JOURNAL OF BIOMEDICAL SCIENCE, 2008, 15 (05) : 565 - 576
  • [10] Metabolic Syndrome and Liver Cancer: is Excess Iron the Link?
    Mascitelli, Luca
    Goldstein, Mark R.
    [J]. HEPATOLOGY, 2011, 54 (04) : 1487 - 1487